Aismay Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Investors
-
12
Aismay General Information
Description
Developer of cancer therapeutics designed for immuno-oncology and bispecific antibody drugs. The company's pharmaceutical products aim to treat and reduce symptoms of various kinds of cancers, enabling healthcare professionals to prescribe more effective treatments to their patients.
Contact Information
Website
www.excelmab.comCorporate Office
- Room 511, 5th Floor, Building B10
- Number 11 Kaiyuan Avenue, Huangpu District
- Guangzhou, Guangdong 510530
- China
Corporate Office
- Room 511, 5th Floor, Building B10
- Number 11 Kaiyuan Avenue, Huangpu District
- Guangzhou, Guangdong 510530
- China
Aismay Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 29-Jul-2026 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 19-Jan-2024 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | 13-Jan-2022 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 12-Jan-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 20-Aug-2021 | Completed | Clinical Trials - General | |||
| 5. Secondary Transaction - Private | 12-Mar-2020 | Completed | Clinical Trials - General | |||
| 4. Early Stage VC (Series A1) | 14-Jan-2020 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC | 30-Jul-2019 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A) | 03-Jan-2018 | $725K | Completed | Clinical Trials - General | ||
| 1. Seed Round | 01-Feb-2017 | $725K | $725K | Completed | Startup |
Aismay Signals
Aismay Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Intellective Bio | VC-Backed Company | Minority | ||
| Wanlian Tianze Capital Investment | Venture Capital | Minority | ||
| Hangzhou Tailong Venture Capital Partnership | Growth/Expansion | Minority | ||
| TigerYeah Capital | Venture Capital | Minority | ||
| Delta Capital | Venture Capital | Minority |
Aismay FAQs
-
When was Aismay founded?
Aismay was founded in 2016.
-
Where is Aismay headquartered?
Aismay is headquartered in Guangzhou, China.
-
What is the size of Aismay?
Aismay has 20 total employees.
-
What industry is Aismay in?
Aismay’s primary industry is Drug Discovery.
-
Is Aismay a private or public company?
Aismay is a Private company.
-
What is Aismay’s current revenue?
The current revenue for Aismay is .
-
How much funding has Aismay raised over time?
Aismay has raised $16.2M.
-
Who are Aismay’s investors?
Intellective Bio, Wanlian Tianze Capital Investment, Hangzhou Tailong Venture Capital Partnership, TigerYeah Capital, and Delta Capital are 5 of 12 investors who have invested in Aismay.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process